Recent News

By Category: Public Health

U.S. Government Expands BioThrax Procurement Contract to 17.92M Doses from 14.5M

BUSINESS WIRE–Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has signed a modification to its current procurement contract (200-2009-30162) with the U.S. government to supply an additional 3.42 million doses of BioThrax® (Anthrax Vaccine Adsorbed). BioThrax is the only vaccine licensed by the U.S. Food and Drug Administration (FDA) to protect against anthrax infection. “Emergent Read More »

May 3, 2011
| Filed under North America, Countermeasures, and Public Health
Share

FDA Warns of Lack of Medical Countermeasures

The Food and Drug Administration has created a five year, 50 page plan called the “Strategic Priorities 2011-2015: Responding to the Public Health Challenges of the 21st Century” that reiterates current programs showing opportunities for growth. The agency has promised to support the Obama administration’s plan to invest nearly $2 billion in measures to counter Read More »

April 26, 2011
| Filed under North America, Countermeasures, Policy & Initiatives, and Public Health
Share

S. Korea reports additional case of foot-and-mouth disease

SEOUL, April 20 (Yonhap) — South Korea reported an additional case of foot-and-mouth disease (FMD) on Wednesday, a week after the government lowered the alert level for the highly contagious disease by one notch.

April 22, 2011
| Filed under Asia/Pacific, Agents & Toxins, Agriculture, and Public Health
Share

CDC Recommends Priorities for Health Agencies

The U.S. Centers for Disease Control and Prevention late last month issued recommendations for how state and local public health officials should direct increasingly tight federal emergency response funds, the Center for Infectious Disease Research and Policy reported on Thursday (see GSN, Dec. 15, 2010). The federal public health agency in past years awarded roughly Read More »

April 18, 2011
| Filed under North America, Policy & Initiatives, and Public Health
Share

Duke Human Vaccine Institute signs research agreement to develop pandemic virus vaccines

(Duke University Medical Center) The Duke Human Vaccine Institute today announced a collaboration and strategic agreement with Novartis Vaccines and Diagnostics to enable the rapid development of a vaccine and accelerate preparedness in case of a pandemic virus threat such as pandemic influenza.